Fiber for Arterial Plaque Ablation DMXR-06

Fiber for Arterial Plaque Ablation DMXR-06

Supplier
Fiberock
Part Number
DMXR-06
Category
Optical Fibers
Origin
China

Technological progress has greatly advanced medicine, particularly timely and important in interventional treatment. Efforts to find disease-prevention/treatment breakthroughs have prompted research and clinical adoption of new techniques. A new minimally invasive intervention combining hybrid surgery is excimer laser coronary atherectomy. Excimer Laser Coronary Atherectomy (ELCA) treats coronary disease with pulsed near-ultraviolet light at 308 nm, using xenon and hydrogen chloride as active media. Tissue penetration is <50μm. Thrombi, plaque, and related tissues absorb the light and are ablated. Fiber catheters deliver UV pulses to plaque. Absorption triggers photochemical reactions breaking molecular bonds, called photoablation. This nonthermal or low-thermal effect is the main mechanism, reducing arterial-wall injury risk. During ELCA, a laser fiber catheter enters the diseased vessel under X-ray fluoroscopy, followed by repeated laser ablation of thrombus/plaque. Three mechanisms contribute: photochemical action, where absorbed pulses break carbon-carbon double bonds and destroy molecular structure; photothermal action, converting energy into heat that denatures proteins and ruptures cells; and photoacoustic action, with pulse-generated shock waves disrupting thrombi/plaque. Indications include balloon-uncrossable/undilatable lesions, including chronic total occlusions (CTO), stent underexpansion, and in-stent restenosis (ISR). Overall, fiber-catheter-delivered excimer light ablates coronary plaque through photochemical reactions without significant arterial-wall thermal injury, particularly for complex lesions difficult to treat with conventional PCI.

Specification Snapshot
Cladding Diameter
660 μm
Coating Diameter
740 μm
Request a Quote Download Datasheet
Save to Favorites Save to Favorites

Overview

Technological progress has greatly advanced medicine, particularly timely and important in interventional treatment. Efforts to find disease-prevention/treatment breakthroughs have prompted research and clinical adoption of new techniques. A new minimally invasive intervention combining hybrid surgery is excimer laser coronary atherectomy. Excimer Laser Coronary Atherectomy (ELCA) treats coronary disease with pulsed near-ultraviolet light at 308 nm, using xenon and hydrogen chloride as active media. Tissue penetration is <50μm. Thrombi, plaque, and related tissues absorb the light and are ablated. Fiber catheters deliver UV pulses to plaque. Absorption triggers photochemical reactions breaking molecular bonds, called photoablation. This nonthermal or low-thermal effect is the main mechanism, reducing arterial-wall injury risk. During ELCA, a laser fiber catheter enters the diseased vessel under X-ray fluoroscopy, followed by repeated laser ablation of thrombus/plaque. Three mechanisms contribute: photochemical action, where absorbed pulses break carbon-carbon double bonds and destroy molecular structure; photothermal action, converting energy into heat that denatures proteins and ruptures cells; and photoacoustic action, with pulse-generated shock waves disrupting thrombi/plaque. Indications include balloon-uncrossable/undilatable lesions, including chronic total occlusions (CTO), stent underexpansion, and in-stent restenosis (ISR). Overall, fiber-catheter-delivered excimer light ablates coronary plaque through photochemical reactions without significant arterial-wall thermal injury, particularly for complex lesions difficult to treat with conventional PCI.

Specifications

ParameterValue
Fiber core diameter600 μm
Cladding Diameter660 μm
Coating Diameter740 μm
Buffer diameter960 μm
Length2.5M/3M
Termination typeSMA905
Numerical Aperture (NA)0.22
Core MaterialPure silica material
Fiber cladding materialFluorine-doped silica material
Coating MaterialAcrylic resin
Buffer materialTeflon
Buffer colorBlue/green/black/white
Operating Temperature-40℃~150ºC
Transmission wavelength190-1100nm
Single-filament transmission efficiency≥90%
CharacteristicsCompliant with biocompatibility requirements
Proof-test strength100kpsi
Fiber TypeStep-index type
REACH reportCompliant with standards
RoHS reportCompliant with standards

Datasheet

Please provide your email to download the datasheet.

Your name
Email Address

Invalid email format. Please try again.

Send Request

Supplier Information

Fi
Fiberock
View Supplier →
Qinhuangdao Guangyan Technology Co., Ltd. (FIBEROCK), located in the Economic and Technological Development Zone, Qinhuangdao, Hebei Province, is a high-tech enterprise focusing on optical fibers, crystal materials, and optical components. The company integrates R&D, production, sales and service, specializing in specialty optical fibers and devices. Its products are widely used in medical treatment, fiber sensing, environmental monitoring equipment, biochemical analytical instruments, laser processing and other fields. The company has advanced specialty fiber drawing production lines and medical-grade clean workshops, and has passed ISO9001 quality system certification.

Request a Quote

Our team responds within 24–48 hours
Fiber for Arterial Plaque Ablation DMXR-06
Fiberock · Optical Fibers
Direct from Manufacturer
Your inquiry will be sent directly to the manufacturer
Photonics Source Platform
We handles the inquiry on your behalf
Your information is protected and will never be shared without consent.
Contact Us

Loading...

GetExperimental Plan

Name

Phone

+86

Organization

Use Case

AI Parametric Selection
Smart Match · Precise Recs
Enter Specifications
AI Smart Matching
Get Best Matches
Skip Manual Comparison
Find Best Solutions Fast
Select Now →